Wednesday, September 2

All session times are in Central Time.

Children categories

Preconference Course (Tuesday, September 1)

Preconference Course (Tuesday, September 1) (1)

This event is an extra-cost event and is not included in the main conference registration fee. 

View items...
4:45 – 6:00 pm
Wednesday, September 2

Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1, Plexiform Neurofibromas, and Optic Pathway Gliomas: Improving Patient Outcomes With an Innovative Therapeutic Approach (SY1)

Join us for this PeerView educational activity on neurofibromatosis type 1 (NF-1) and plexiform neurofibromas (PNs). An expert panel will provide insight into the expanding landscape of targeted therapies and will discuss optimal clinical decision-making for patients with NF-1 and NF-1─related PNs that are based on the latest evidence, best practice recommendations, and effective interdisciplinary collaboration. 

APHON thanks Astra Zeneca for their generous support of this event. 

10:45 – 11:45 am

What Every Nurse Needs to Know About Drug Shortages (202)

Shortages of essential drugs can have a significant impact on the health of children worldwide. In pediatric oncology, drug shortages are particularly impactful. Childhood cancer treatment relies heavily on the use of sterile injectable generic agents, which make up the majority of scarce medications.

Speaker:
Dyane Bunnell, MSN APRN AOCNS CPON®
Susie Burke, MA BSN CPNP CPHON®
Michele Casey, MN NP RN
Caity Hubrig, BSN RN CPN CPHON®
CNE Hours
1
10:45 – 11:15 am

First Victim, Second Victim.....Do No Harm (203-1)

In November 1999, the Institute of Medicine released its landmark report "To Err is Human," which outlined the looming patient safety crisis affecting healthcare facilities. It was suggested in this report that up to 98,000 patients per year were the victims of medical errors.

Speaker:
Beth Fisher, DNP APRN CPNP CPON®
CNE Hours
0.5
11:15 – 11:45 am

Reducing Preventable Harm: Quality Improvement Strategies to Reduce Chemotherapy/Biotherapy Medication Administration Errors (203-2)

Medication administration errors (MAE) are among the most common adverse events causing patients during treatment. These events are nearly always preventable. Although any MAE is problematic, patients treated with chemotherapy and biotherapy agents are at risk for significant harm due to the inherent hazards of the medications and the complexity of treatment protocols.

Speaker:
Mindy Bibart, MSN RN  NE-BC CSSBB CPHON®
CNE Hours
0.5